1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Song, J.
Laskowski Jr., M.
Qasim, M.A.
Markley, J.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
42
6380
6391
10.1021/bi034053f
12767219
Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
2003
10.2210/pdb1m8c/pdb
pdb_00001m8c
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
6044.783
Ovomucoid
RESIDUES 130-185; KAZAL-LIKE 3 (INHIBIT CHYMOTRYPIN, ELASTASE, ETC.)
P14D
1
syn
polymer
no
no
LAAVSVDCSEYPKDACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC
LAAVSVDCSEYPKDACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-09-04
1
1
2008-04-28
1
2
2011-07-13
1
3
2021-10-27
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_ref_seq_dif.details
SOLUTION STRUCTURE OF THE C State OF TURKEY OVOMUCOID AT PH 2.5
RCSB
Y
RCSB
2002-07-24
REL
The sequence for Ovomucoid fragment was chemically synthesized. It occurs naturally in Meleagris gallopavo (Common turkey).
sample
structures with favorable non-bond energy
50
20
3D_13C-separated_NOESY
3D_15N-separated_NOESY
2D NOESY
2D NOESY
no salt added
2.5
ambient
298
K
torsion angle dynamics, simulated annealing
1
lowest energy
1 mM
90% H2O/10% D2O
1 mM
100% D2O
collection
XwinNMR
3.2
processing
Felix
95
data analysis
Sparky
3.72
structure solution
DYANA
1.5
refinement
DYANA
1.5
750
Bruker
DMX
600
Bruker
AMX
500
Bruker
DMX
LEU
1
n
1
LEU
1
A
ALA
2
n
2
ALA
2
A
ALA
3
n
3
ALA
3
A
VAL
4
n
4
VAL
4
A
SER
5
n
5
SER
5
A
VAL
6
n
6
VAL
6
A
ASP
7
n
7
ASP
7
A
CYS
8
n
8
CYS
8
A
SER
9
n
9
SER
9
A
GLU
10
n
10
GLU
10
A
TYR
11
n
11
TYR
11
A
PRO
12
n
12
PRO
12
A
LYS
13
n
13
LYS
13
A
ASP
14
n
14
ASP
14
A
ALA
15
n
15
ALA
15
A
CYS
16
n
16
CYS
16
A
THR
17
n
17
THR
17
A
LEU
18
n
18
LEU
18
A
GLU
19
n
19
GLU
19
A
TYR
20
n
20
TYR
20
A
ARG
21
n
21
ARG
21
A
PRO
22
n
22
PRO
22
A
LEU
23
n
23
LEU
23
A
CYS
24
n
24
CYS
24
A
GLY
25
n
25
GLY
25
A
SER
26
n
26
SER
26
A
ASP
27
n
27
ASP
27
A
ASN
28
n
28
ASN
28
A
LYS
29
n
29
LYS
29
A
THR
30
n
30
THR
30
A
TYR
31
n
31
TYR
31
A
GLY
32
n
32
GLY
32
A
ASN
33
n
33
ASN
33
A
LYS
34
n
34
LYS
34
A
CYS
35
n
35
CYS
35
A
ASN
36
n
36
ASN
36
A
PHE
37
n
37
PHE
37
A
CYS
38
n
38
CYS
38
A
ASN
39
n
39
ASN
39
A
ALA
40
n
40
ALA
40
A
VAL
41
n
41
VAL
41
A
VAL
42
n
42
VAL
42
A
GLU
43
n
43
GLU
43
A
SER
44
n
44
SER
44
A
ASN
45
n
45
ASN
45
A
GLY
46
n
46
GLY
46
A
THR
47
n
47
THR
47
A
LEU
48
n
48
LEU
48
A
THR
49
n
49
THR
49
A
LEU
50
n
50
LEU
50
A
SER
51
n
51
SER
51
A
HIS
52
n
52
HIS
52
A
PHE
53
n
53
PHE
53
A
GLY
54
n
54
GLY
54
A
LYS
55
n
55
LYS
55
A
CYS
56
n
56
CYS
56
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
TYR
31
A
O
TYR
31
A
N
LEU
23
A
N
LEU
23
A
N
CYS
24
A
N
CYS
24
A
O
HIS
52
A
O
HIS
52
3
A
A
O
H
GLY
ASN
25
28
1.55
3
A
A
O
H
PRO
ALA
12
15
1.59
4
A
A
O
HG
VAL
SER
41
44
1.57
7
A
A
O
H
GLY
ASN
25
28
1.57
10
A
A
O
H
GLY
ASN
25
28
1.57
11
A
A
O
HG1
SER
THR
44
47
1.39
14
A
A
O
H
GLY
ASN
25
28
1.57
14
A
A
OD1
HG
ASP
SER
7
9
1.59
1
A
ALA
3
-174.23
121.66
1
A
THR
17
-133.44
-137.46
1
A
GLU
19
-66.91
99.36
1
A
ASN
28
82.74
35.09
1
A
ASN
45
89.04
3.93
2
A
ALA
2
41.04
79.81
2
A
ALA
15
-164.03
103.40
2
A
CYS
16
168.58
63.53
2
A
LEU
18
82.04
-55.70
2
A
ASN
28
82.54
31.97
2
A
HIS
52
-175.95
-177.49
3
A
ALA
3
-68.38
75.73
3
A
VAL
4
-49.78
166.01
3
A
TYR
11
-157.24
67.24
3
A
CYS
16
-174.76
87.16
3
A
THR
17
-62.05
-129.45
3
A
ASN
28
83.71
27.21
4
A
ALA
2
61.14
89.39
4
A
ALA
15
-109.93
63.25
4
A
CYS
16
-175.65
105.72
4
A
THR
17
-133.42
-130.91
4
A
LEU
18
-39.43
-36.91
4
A
GLU
19
-65.92
95.98
4
A
HIS
52
-176.37
-179.98
5
A
ALA
2
40.65
77.20
5
A
SER
5
-175.11
141.24
5
A
ALA
15
-163.00
101.56
5
A
CYS
16
170.36
42.86
5
A
LEU
18
84.62
-50.09
5
A
ASN
28
81.39
27.13
6
A
SER
5
63.09
125.01
6
A
CYS
8
-92.11
40.53
6
A
TYR
11
-175.02
80.19
6
A
CYS
16
-174.09
61.17
6
A
LEU
18
80.13
-54.28
6
A
LEU
48
-39.92
145.09
6
A
HIS
52
-175.71
-179.24
7
A
ALA
2
-55.93
-171.99
7
A
SER
5
-172.40
131.60
7
A
CYS
8
-101.48
43.52
7
A
TYR
11
-154.11
76.72
7
A
ALA
15
-145.18
58.32
7
A
CYS
16
-151.80
-105.32
7
A
THR
17
52.58
172.79
7
A
LEU
18
69.99
-61.89
7
A
THR
49
-124.40
-168.91
8
A
ALA
2
59.61
71.18
8
A
SER
5
64.31
116.31
8
A
THR
17
-64.29
-149.95
8
A
ASN
28
84.01
37.85
8
A
HIS
52
-175.03
-177.18
9
A
TYR
11
179.82
88.83
9
A
ALA
15
-88.73
-122.82
9
A
CYS
16
41.42
74.67
9
A
LEU
18
77.36
-59.68
9
A
ASN
45
80.07
11.84
9
A
LEU
48
-39.05
154.69
10
A
ALA
3
65.76
116.08
10
A
SER
5
66.32
118.51
10
A
TYR
11
-168.48
88.26
10
A
ALA
15
-108.65
-81.67
10
A
CYS
16
45.75
26.77
10
A
THR
17
36.79
-151.12
10
A
ASN
28
81.56
30.47
10
A
LEU
48
-37.56
145.42
11
A
ALA
2
-103.87
76.89
11
A
TYR
11
-165.19
91.38
11
A
ALA
15
-79.49
-101.33
11
A
CYS
16
42.14
85.07
11
A
THR
17
-66.88
-140.13
11
A
ASN
28
72.11
30.60
11
A
LEU
48
-38.89
147.79
12
A
ALA
2
45.88
-162.93
12
A
ALA
3
67.88
82.76
12
A
VAL
4
55.99
163.43
12
A
SER
5
-179.68
123.93
12
A
TYR
11
-175.93
73.69
12
A
ALA
15
-172.80
74.54
12
A
CYS
16
-179.15
59.10
12
A
LEU
18
84.81
-55.04
12
A
GLU
19
-66.35
99.87
12
A
ASN
28
81.92
26.36
12
A
THR
49
-119.58
-167.47
12
A
LYS
55
-49.86
171.30
13
A
TYR
11
-160.43
91.97
13
A
CYS
16
-164.63
99.26
13
A
THR
17
-131.51
-131.06
13
A
LEU
18
-39.85
-29.84
13
A
GLU
19
-65.22
97.79
13
A
ASN
28
81.73
30.22
13
A
LEU
48
-39.09
141.02
14
A
ALA
2
-44.27
163.86
14
A
ALA
3
67.47
160.85
14
A
SER
5
-169.78
110.84
14
A
TYR
11
-159.02
79.21
14
A
ALA
15
-117.34
-125.74
14
A
CYS
16
57.29
103.90
14
A
THR
17
-67.69
-139.02
14
A
GLU
19
-69.07
96.07
14
A
LYS
55
-42.69
160.63
15
A
ALA
2
-140.36
55.75
15
A
SER
5
179.40
165.22
15
A
TYR
11
-171.72
87.65
15
A
ALA
15
-101.82
-123.85
15
A
CYS
16
55.91
102.22
15
A
THR
17
-61.26
-139.86
15
A
ASN
28
83.18
36.09
15
A
LEU
48
-39.31
144.42
15
A
LYS
55
-43.17
158.90
16
A
VAL
4
57.78
163.65
16
A
SER
5
178.21
131.47
16
A
TYR
11
-150.75
89.13
16
A
THR
17
-117.82
-126.52
16
A
LEU
18
-39.80
-29.30
16
A
GLU
19
-64.82
96.04
16
A
ASN
28
82.89
37.09
16
A
LEU
48
-39.90
136.40
16
A
LYS
55
-41.52
153.61
17
A
ALA
3
-103.65
69.62
17
A
SER
5
-179.64
135.91
17
A
TYR
11
-167.16
86.02
17
A
CYS
16
174.65
109.20
17
A
THR
17
-133.23
-126.38
17
A
LEU
18
-39.44
-34.68
17
A
ASN
28
72.85
35.50
17
A
HIS
52
-173.67
-175.71
18
A
ALA
2
173.24
50.98
18
A
ALA
3
175.07
178.77
18
A
CYS
16
178.17
113.11
18
A
THR
17
-138.08
-139.75
18
A
ASN
28
73.79
40.74
18
A
HIS
52
-176.01
-176.21
19
A
VAL
4
58.15
164.78
19
A
CYS
16
-167.26
105.54
19
A
THR
17
-131.09
-133.44
19
A
GLU
19
-65.68
97.60
19
A
ASN
28
83.94
43.22
19
A
LEU
48
-38.86
136.56
20
A
ALA
3
-169.33
67.65
20
A
TYR
11
-170.52
88.10
20
A
CYS
16
177.01
105.92
20
A
THR
17
-138.82
-119.83
20
A
LEU
18
-39.21
-36.27
20
A
ASN
28
78.72
33.44
20
A
LEU
48
-39.87
150.63
20
A
THR
49
-126.49
-169.00
SOLUTION STRUCTURE OF THE T State OF TURKEY OVOMUCOID AT PH 2.5
1
N
N
A
ASN
33
A
ASN
33
HELX_P
A
SER
44
A
SER
44
1
1
12
disulf
2.099
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.036
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
35
A
SG
CYS
35
1_555
disulf
2.097
A
CYS
24
A
SG
CYS
24
1_555
A
CYS
56
A
SG
CYS
56
1_555
HYDROLASE INHIBITOR
OMTKY3 CONFORMATIONAL TRANSITION T STATE, CIS-TRANS ISOMERIZATION, HYDROLASE INHIBITOR
IOVO_MELGA
UNP
1
130
P01004
LAAVSVDCSEYPKPACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC
130
185
1M8C
1
56
P01004
A
1
1
56
1
PRO
engineered mutation
ASP
14
1M8C
A
P01004
UNP
143
14
3
anti-parallel
anti-parallel
A
THR
30
A
THR
30
A
TYR
31
A
TYR
31
A
LEU
23
A
LEU
23
A
GLY
25
A
GLY
25
A
LEU
50
A
LEU
50
A
PHE
53
A
PHE
53
1
P 1